Our methodology is based on the enrichment of chromatin associated to FANCD2, a protein that has been described to localize specifically to CFS in G2/M cells (23) (Figure 1A). Here, FANCD2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.